Cannara Biotech Inc. (LOVFF)

Cannara Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 6, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	126	120	45	67	91	118
Market Cap Growth	150.64%	164.10%	-32.08%	-26.24%	-23.18%	119.59%
Enterprise Value	145	144	78	97	112	127
Last Close Price	1.30	1.33	0.54	0.75	1.00	1.30
PE Ratio	13.21	12.59	9.51	13.02	51.35	-
PS Ratio	1.61	1.54	0.75	1.58	3.30	8.75
PB Ratio	1.69	1.61	0.70	1.13	1.77	2.32
P/TBV Ratio	1.69	1.61	0.70	1.13	1.77	2.32
P/FCF Ratio	12.65	12.05	19.05	-	-	-
P/OCF Ratio	8.63	8.22	5.73	15.29	-	-
EV/Sales Ratio	1.88	1.84	1.28	2.29	4.07	9.40
EV/EBITDA Ratio	7.09	7.04	7.62	7.92	16.91	58.11
EV/EBIT Ratio	9.28	9.13	13.69	11.17	30.25	3041.19
EV/FCF Ratio	14.63	14.47	32.55	-	-	-
Debt / Equity Ratio	0.41	0.41	0.55	0.57	0.73	0.33
Debt / EBITDA Ratio	1.47	1.47	3.45	2.75	5.54	7.15
Debt / FCF Ratio	3.05	3.05	15.04	-	-	-
Asset Turnover	0.66	0.66	0.55	0.43	0.33	0.23
Inventory Turnover	1.32	1.32	1.41	1.14	1.40	1.39
Quick Ratio	0.83	0.83	0.73	0.70	1.75	1.63
Current Ratio	2.40	2.40	2.50	2.44	3.46	2.82
Return on Equity (ROE)	13.75%	13.75%	7.68%	9.48%	3.52%	-2.98%
Return on Assets (ROA)	8.37%	8.37%	3.23%	5.48%	2.77%	0.04%
Return on Capital (ROIC)	9.67%	9.67%	3.65%	6.09%	3.01%	0.05%
Return on Capital Employed (ROCE)	16.10%	16.10%	6.00%	9.70%	4.20%	0.10%
Earnings Yield	7.57%	7.95%	10.52%	7.68%	1.95%	-1.03%
FCF Yield	7.90%	8.30%	5.25%	-4.39%	-18.20%	-22.26%
Buyback Yield / Dilution	-1.08%	-1.08%	-1.83%	-2.16%	-14.80%	-7.26%

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.